Shilpa Medicare receives USFDA approvals for Docetaxel injection
Shilpa Medicare has received final USFDA approval for Docetaxel Injection, used for treatment of various types of cancers. The company will market the inaction in […]
Shilpa Medicare
Shilpa Medicare receives USFDA approval for Gemcitabine injection
Shilpa Medicare has received USFDA approval for Gemcitabine injection, used for treatment of various types of cancers. The product Gemcitabine is a generic equivalent of […]
Shilpa Medicare receives USFDA approval for Irinotecan HCL injection
Shilpa Medicare has received final USFDA approval for Irinotecan HCL injection to market the same in US. The injection drug will be marketed in the […]
Shilpa Medicare receives USFDA approval for Azacitidine injection
Shilpa Medicare has received USFDA approval of Azacitidine injection which is used in the treatment of myelodysplastic syndrome. Myelodysplastic syndrome is a condition that affects […]